Navigation Links
CorMedix Receives Minutes from Neutrolin Pre-IND Meeting with FDA
Date:12/23/2013

Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or CorMedix's prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: risks of launch and market acceptance of our products; obtaining regulatory approvals to conduct clinical trials and to commercialize CorMedix's product candidates; the risks and uncertainties associated with CorMedix's ability to manage its limited cash resources; obtaining additional financing to support CorMedix's research and development and clinical activities and operations; CorMedix's ability to maintain its listing on the NYSE MKT; the outcome of clinical trials of CorMedix's product candidates and whether they demonstrate these candidates' safety and effectiveness; CorMedix's ability to enter into and maintain collaborations with third parties for its development programs; CorMedix's dependence on its collaborations and its license relationships; achieving milestones under CorMedix's collaborations; CorMedix's dependence on preclinical and clinical investigators, preclinical and clinical research organizations, manufacturers and consultants; and protecting the intellectual property developed by or licensed to CorMedix. These and other risks are described in greater detail in CorMedix's filings with the SEC, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from CorMedix. CorMedix may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. CorMedix assumes no obligation and does not intend to update these forward-looking statement
'/>"/>
SOURCE CorMedix Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CorMedix to Report Third Quarter Financial Results on November 19, 2013
2. CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings
3. CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
4. CorMedix Reports Second Quarter 2013 Results
5. CorMedix Granted Extension of NYSE MKT Listing
6. Philips receives FDA clearance for First-Ever Spectral Breast Density Measurement Application
7. Caris Life Sciences Receives Tumor Profiling Industrys First ISO 15189 Medical Laboratory Accreditation
8. Synapse Biomedical Receives $2.4 Million
9. Cell Therapeutics Receives Remaining $5 million Under Existing Loan Financing Agreement
10. Mobius Imaging Receives ISO 13485 Certification
11. Oramed Receives Allowance on its Core Oral GLP-1 Technology Patent in Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- Kinex Pharmaceuticals announced today that the first patient ... Institute. KX2-361 (KX02), a dual src/pre-tubulin inhibitor, ... inhibitory activity against a broad panel of brain tumor ... (T98G), the most widely used chemotherapy for the treatment ... model, KX2-361 consistently clears brain tumors after 4 weeks ...
(Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
(Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... 2011 SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that ... over-the counter (OTC) market beginning January 13, 2011 under the ... quoted on the OTC Bulletin Board and OTCQB™ Market on ... NYSE Amex Exchange at the close of business on January ...
... remote instrument support has expanded to include the Ventana ... is the leading innovator in the application of remote ... on the SYMPHONY H&E slide stainer. VMSI is now ... integration of the SYMPHONY and BenchMark platforms. For customers, ...
Cached Medicine Technology:SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011 2CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 2CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 3
(Date:12/26/2014)... The Biofeedback Federation of Europe annual ... in Rome, Italy and is hosted by the Salesian ... on a wide variety of topics such as ADHD, ... training in athletes. The scientific program will feature the ... monitoring allows clients to see what is going on ...
(Date:12/26/2014)... 2014 “Many people become overwhelmed by ... claim issues and phone calls with insurance companies,” The ... featuring their free eBook on pedestrian and bicycle ... pedestrian and bicycle auto accident claims assures the injured ... of professionally handling their case while they focus on ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on the ... for 2014. The awards program, created in 2000, is ... in the country. The program is a public/private partnership ... and Economic Development, the Pennsylvania State Council of the ... Business Journal. , Charlie Wilson, Vice President ...
(Date:12/26/2014)... 26, 2014 Parker & Sons, ... best in heating, cooling and plumbing contractor services ... emergency services in 2014 with regard to air-conditioning ... Arizona is known for its incredibly hot summers. ... the intricacies and details of a wide variety ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... current state of the global Sterilizers industry with a ... statistics on the market status of the Sterilizers manufacturers ... for companies and individuals interested in the industry. This ... its definition, applications and manufacturing technology. In this part, ...
Breaking Medicine News(10 mins):Health News:Final Workshop Line-up Announced for 18th Annual Biofeedback Conference in Rome, Italy 2Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3
... Jan. 23 U.S. Environmental,Protection Agency Region 5 has ... Canton, Ohio, for a project to cut diesel emissions ... will be used to retrofit 24 school buses with,equipment ... two 1988,school buses with new, low-emission 2007 model year ...
... Planet, a company,founded on the principle of hearing ... has been awarded a patent for its,innovative LINX ... a new generation of top-of-the-line hearing aids, delivers ... the perception of,loudness without forcing users to crank ...
... Chelle Brewer,s, story of triumph over adversity is representative of military spouse ... ... 27-year-old Chelle Brewer,s soldier,husband is nearing the end of a half year ... training accident. Her,three-year old daughter was born with half a heart. She ...
... Client, Joel, Hopkins, President and CEO of Dominion Healthcare Services, Inc. and ... ... law firm announced,today that they have filed a lawsuit on behalf of their ... suit was filed to expose the misconduct and wrongdoings of,Durham County LME, Wake ...
... the brain region that controls the decision to halt ... of that leftover chicken leg. Whats more, they said, ... in addiction and mental illness., Emmanuel Procyk and colleagues ... of the journal Neuron, published by Cell Press. , ...
... found that field mice have evolved a unique way of ... of infertility in humans. , The team, in collaboration ... of their immunity protection in favour of a more rapid ... a protein, called CD46. Present in both animals and ...
Cached Medicine News:Health News:EPA Awards $154,848 Grant to Canton Local School District for Clean School Bus Project 2Health News:Company's Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands 2Health News:'Military Spouse of the Year 2008' Announced 2Health News:The Willie Gary Law Firm Files $1 Billion Lawsuit Against Durham County LME, Wake County LME, Five County LME, Mecklenberg County LME and Value Options, Inc. for Negligent and Intentional Misconduct Against Mental Health Agency 2Health News:Researchers identify brain's 'eureka' circuitry 2Health News:Evolutionary phenomenon in mice may explain human infertility 2
HemoSite meter can be used to measure the effects of transfusion or the treatment of deficiency states. It is fast, easy, convenient and discrete....
... test system is the worlds ... test system designed for use ... clinics, blood centers and emergency ... is designed for the point-of-care ...
... hemoglobin testing system (110V) ... for diabetes monitoring, sickle ... hemoglobinopathy screening and multiple ... test. It has bar ...
The Advia 60 is designed to deliver powerful performance in a small package....
Medicine Products: